Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning: Multicentric Video Collection for Minimally Invasive Sentinel Lymph Node Dissection in Uterine Malignancies
NCT ID: NCT06619002
Last Updated: 2024-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2024-09-17
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
These limitations are a result of the lack of precision of current SLN localization and analysis as well as of the overall difficulty of visualizing lymph nodes and other critical structures in the retroperitoneum.
Currently, studies on the safety of surgical procedures are based on perioperative clinical information and postoperative reports written by the surgeons themselves. Today, videos guiding minimally invasive surgical interventions allow for objective documentation of the procedure and provide opportunities to explore solutions for enhancing safety in the operating room. With an increasing use of endoscopic systems across different specialties, there is a need for standardization of training, assessment, testing and sign-off as a competent surgeon in order to improve patient safety. In laparoscopic lymph node dissection in endometrial and cervical cancer, a standardize stepwise approach to the procedure is highly recommended, by identifying key anatomic landmarks and structures, in various scenarios, that could prevent vascular, nervous and ureters injuries and enhance the mapping rate. Therefore, quantifying and studying intraoperative events such as the rate of achieving the right space dissections and anatomic structures visualization as a recommended step for safety and proficiency, would enable the examination of how best to implement guideline recommendations and seek new solutions to reduce operative risks. These videos could be utilized to train and validate artificial intelligence (AI) algorithms, with the potential to assist surgeons in the operating room and make the procedures safer. Additionally, the visual information (ICG intensity) could hide data that the AI can analyze and correlate with anatomopathological reports. By the integration of AI tool with laparoscopic/robotic platform it is possible to enhance MIS video streams in real time with surgical phases detection, events recognition, ICG signal intensity, anatomical structure identification and auto-targeting
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer
NCT04227249
Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer
NCT01527396
Lower-Limb Drainage Mapping in Pelvic Lymphadenectomy for Gynaecological Cancer
NCT01946672
Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.
NCT02598219
Prediction of Ovarian Cancer Histotypes and Surgical Outcome
NCT07057167
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Furthermore, recent advancements in Artificial Intelligence (AI) have shown great success in image understanding, raising the possibility of developing algorithms for automatic and large-scale analysis of surgical videos. These AI algorithms could also analyze surgical videos in real-time and provide decision support in the operating room.
The assessment of lymph node status is of crucial importance in uterine malignancies (endometrial and cervical cancer). The rate of positive lymph nodes in apparently early stage cancers is far to be low (10% endometrial and cervical 15% ). Indeed, the prognosis and adjuvant treatment regimens are strongly influenced by the presence of nodal involvement. Systematic extensive lymphadenectomies are often performed for staging, diagnosis of skip metastases and to define the radiation field when adjuvant radiotherapy treatments are required. Nevertheless, pelvic and/or para- aortic lymphadenectomy can lead to significant short-term and long-term complications.
What makes the burden of surgical morbidity even more difficult to bear is that in most cases, regardless of the type of pelvic malignancy, the lymph nodes are free from metastasis. This means that the majority of patients undergo an unnecessary, risky, and burdensome procedure that has no proven impact on their survival. To solve this issue in early stage endometrial and cervical cancers, evaluation of the sentinel lymph node (SLN) has acquired a valuable role..The evaluation of the first lymph node or group of lymph nodes draining the initial lesion and therefore the first station to collect neoplastic cells in case of tumor nodal spread allows node-negative patients to be spared from the surgical comorbidities associated with systematic lymphadenectomy. However even if only SLN is removed, the rate of surgical complications is still high. Capozzi et al reported a 11.2% complications rate related to intra- operative injuries of vessels, nerves, and ureters and to post-operative evidence of lymphoceles and lymphedemas due to wrong anatomy dissection and lymphatic channels disruption. It is reported a 25% of SLN mapping failure according to patients and cancer characteristics and variability in the surgical steps. In 2021 Moloney et al and in 2023 Bizzarri et al published a Delphi consensus for SLN surgical steps in endometrial and cervical cancer to improve the clinical outcomes, decrease surgical complications and bias in multicentric prospective trials. To date a learning curve of 40 procedures is demonstrated to be needed for successful bilateral mapping. Furthermore, in some case it is reported the inadvertent failure to harvest nodal tissue in 14% of cases (higher rate in obese patients with endometrial cancer) with empty packets that may lead to overtreatment for patient safety. Sentinel node frozen section analysis tough then is not routinely performed due to its disadvantage in terms of time consumption and not accurate results for micro-metastasis detection (65% of detection accuracy) thereby losing part of the techniques potential.
In laparoscopic cholecystectomy, the critical view of safety (CVS) has been described to reduce the risk of bile duct injury. We aim to adapt concepts of "culture of safety" to laparoscopic SLN node dissection by identifying key anatomic landmarks and structures, in various scenarios, that could prevent intra- operative injuries and enhance the mapping rate by following the standardized surgical steps.
Therefore, quantifying and studying intraoperative events such as the rate of achieving the recommended surgical steps, would enable the examination of how best to implement guideline recommendations and seek new solutions to reduce operative risks. Furthermore, these videos could be utilized to train and validate artificial intelligence (AI) algorithms, with the potential to assist surgeons in the operating room helping in the training to reach faster the learning curve and improve the procedural safety. Infact, recent AI algorithms capable of automatically assessing and documenting the critical view of safety (CVS) with short videos could be utilized to support the implementation of guidelines and make laparoscopic SLN dissection safer.
Analyzing videos of laparoscopic SLN dissection performed at referral centers could help assess the implementation of a stepwise approach to the procedure and the development of a critical view of safety (CVS) along with other guideline recommendations, as well as develop new solutions for safe laparoscopic SLN dissection. The steps to identification and the "Critical view of safety" are fully described in the study. Our project emphasizes the importance of achieving these views of safety before proceeding to the next step of the procedure. The next step involves analysing the intensity of the fluorescent signal and correlating it, as no-one has ever done, with the histological diagnosis of the sentinel lymph node to assess the possibility of correlation between intensity and metastatic nature.
Additionally, AI algorithms for safe laparoscopic SLN dissection could be tested on the collected videos from multiple hospital centers to adequately study the generalizability of these algorithms before clinical translation.
Purposes and objective of the clinical study:
The objective of this study is to establish the rate of critical view of safety (CVS) for safe laparoscopic SLN dissection in a multicentre cohort of surgical videos to reduce complications, the surgical learning curve and correlate ICG intensity with the lymph node metastatic nature
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sentinel lymph node sampling
video analysis
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Availability of video
* Age \>18 years
* Willingness to participate in the study and to provide informed consent
Exclusion Criteria
* Severe endometriosis or other conditions able to alter the pelvic anatomy
18 Years
99 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IHU Strasbourg
OTHER
University Hospital, Strasbourg
OTHER
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bizzarri Nicolò
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matteo PAVONE, MD
Role: PRINCIPAL_INVESTIGATOR
Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome Italy; IHU Strasbourg; IRCAD Strasbourg; Icube Strasbourg;
Nicolò BIZZARRI, MD
Role: PRINCIPAL_INVESTIGATOR
Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome Italy
Lise LECOINTRE, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospitals of Starsbourg; Icube Strasbourg; IHU Strasbourg
Denis QUERLEU, MD, PhD
Role: STUDY_CHAIR
Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome Italy
Nicolas PADOY, PhD
Role: STUDY_CHAIR
IHU Strasbourg
Giovanni SCAMBIA, MD, PhD
Role: STUDY_DIRECTOR
Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome Italy
Francesco FANFANI, MD, PhD
Role: STUDY_CHAIR
Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome Italy
Cherif AKLADIOS, MD, PhD
Role: STUDY_CHAIR
University Hospitals of Strasbourg
Pietro MASCAGNI, MD, PhD
Role: STUDY_CHAIR
Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome Italy
Valentina IACOBELLI, MD
Role: STUDY_CHAIR
Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome Italy
Andrea ROSATI, MD
Role: STUDY_CHAIR
Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, , Italy
Fondazione Policlinico Universitario A. Gemelli IRCCS
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Matteo Pavone, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID 6672
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.